Nihon Dengi (1723) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
2 Feb, 2026Executive summary
Net sales for the nine months ended December 31, 2024, increased by 4.6% year-over-year to ¥26,173 million.
Operating profit rose 46.7% year-over-year to ¥5,753 million, and ordinary profit increased 46.3% to ¥5,909 million.
Profit attributable to owners of parent grew 41.8% year-over-year to ¥3,899 million.
Financial highlights
Gross profit rose to ¥11,397 million from ¥9,054 million year-over-year.
Earnings per share for the nine months was ¥244.89, up from ¥172.27 in the prior year period.
Comprehensive income increased to ¥4,320 million from ¥3,188 million year-over-year.
Total assets as of December 31, 2024, were ¥47,631 million, up from ¥46,021 million as of March 31, 2024.
Net assets increased to ¥37,269 million, with an equity ratio of 78.2%.
Outlook and guidance
Full-year net sales forecasted at ¥42,500 million, a 9.3% year-over-year increase.
Operating profit projected at ¥7,500 million (up 20.0%), ordinary profit at ¥7,600 million (up 20.2%), and profit attributable to owners of parent at ¥5,300 million (up 13.4%).
Full-year earnings per share forecasted at ¥332.85.
Year-end dividend forecast at ¥108.00 per share, with total annual dividend at ¥184.00 per share.
Latest events from Nihon Dengi
- Operating profit and net profit rose sharply despite lower sales, with robust full-year guidance.1723
Q1 20252 Feb 2026 - Profits hit record highs and forecasts were raised despite a 3.8% drop in sales.1723
Q2 20252 Feb 2026 - Record-high profits, double-digit growth, and a stock split set the stage for stable outlook.1723
Q4 20252 Feb 2026 - Strong quarterly growth in sales and profit, with a positive full-year outlook and higher dividends.1723
Q1 20262 Feb 2026 - Record first-half earnings and raised full-year outlook amid robust demand and growth.1723
Q2 20262 Feb 2026 - Strong profit and sales growth with higher dividends forecast for the full year.1723
Q3 20262 Feb 2026